Physician profile
Amy Piland
NPI 1063240075
$1,476.74
in general payments reported to CMS, 2019-2025
6 companies · $1,477 in 2025
The $1,477 reported for 2025 was more than what 92% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $1,477.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,046 · Travel and Lodging: $431.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,045.69 |
| Travel and Lodging | $431.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,029.50 | 2025 | General - Vascular Intervention, Enroute Transcarotid Neuroprotection System |
| Endologix LLC | $196.07 | 2025 | Afx2 Bifurcated Endograft System, Alto Abdominal Stent Graft System |
| Penumbra, INC. | $174.11 | 2025 | Penumbra System |
| Neuros Medical, INC. | $41.94 | 2025 | Altius |
| Merck Sharp & Dohme LLC | $20.50 | 2025 | Verquvo |
| Biotronik INC. | $14.62 | 2025 | Acticor 7 Vr-T Dx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Piland listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.